Section 17-8309. AUTHORITY TO COLLECT INFORMATION AND RECORD RETENTION

 

8309.1In carrying out its functions under the Act, the Board of Pharmacy and an agent acting on its behalf is authorized to collect information from licensed pharmaceutical detailers relating to their communications with licensed health professionals, or with employees or representatives of licensed health professionals, located in the District.

 

8309.2Upon receipt of a verbal or written request by the Board or its agent for information pursuant to § 8309.1 of this chapter, a pharmaceutical detailer shall provide the requested information within ten (10) business days of the request.

 

8309.3Refusal by a pharmaceutical detailer to provide the requested information with the time allotted shall constitute a basis for disciplinary action under the Health Occupations Revision Act of 1985, effective march 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1201.01 et seq.)

 

8309.4A pharmaceutical detailer shall retain documents and information relating to his or her communications with licensed health professionals, or with employees or representatives of licensed health professionals, located in the District for a period of five years from the date of the communication or contact.

 

8309.5Within ten (10) days of leaving the employ of a pharmaceutical company, a pharmaceutical detailer shall provide written notification to the Board of his or her departure and the name, address, email, and telephone number of the person within the company who may be contacted for retrieving the records required to be maintained under this chapter.

 

8309.6 For purposes of complying with this section, a pharmaceutical detailer shall maintain documents and information relating to his or her communications with licensed health  professionals or with employees or representatives of licensed health professionals that  include but are not limited to: 

 

(a)  The name, business address, and telephone number of the healthcare

professional the detailer visited;

 

(b) The date, time and location of the visit:

 

(c)  The products discussed;

 

(d)  Whether samples were provided; and

 

(e)  The type of materials provided to the health care professional, if applicable.

 

authority

Pursuant to the District of Columbia Health Occupations Revision Act of 1985, effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1203.02(14)), Mayor's Order 98-140, dated August 20, 1998, the SafeRx Amendment Act of 2008, effective March 26, 2008 (D.C. Law 17-0131; 55 DCR 4462, published on April 25, 2008) (the Act), and Mayor’s Order 2008-94, dated July 3, 2008.

source

Final Rulemaking published at 55 DCR 9317 (August 29, 2008); as amended by Final Rulemaking Published at 56 DCR 2951 (April 17, 2009).